ã¯ãã€ãã³ã«äœçœ®ãããã«ãã³ã»ãã³ãã³ã»ã¯ãã€ãã³ã¯ããã®4ã€æã®è©äŸ¡ã«ãµããããããšã¬ã¬ã³ãããšå¿«é©ããå
ŒãåããŠããŸãã宿æ³å®¢ã¯ããã«ã®æœèšã«æºè¶³ããŠããããã®è³ªã®é«ããšæž
æœã§ã¢ãã³ãªå
è£
ã匷調ããŠããŸããæœèšã¯çŸããç¶æãããŠãããçŸä»£çãªçŸåŠãéç«ã€ãã€ã¹ããã¯ãªäŒå ŽãæäŸããŠããŸãã
ããã«ã§æäŸããããµãŒãã¹ã¯ãç¹ã«COVID-19ã®ãããã³ã«ãéµå®ãããäžå¯§ã§ãã¬ã³ããªãŒãªã¹ã¿ãããé«ãè©äŸ¡ãããŠããŸããæé£ãµãŒãã¹ã¯ãã®è³ªãè©äŸ¡ãããŠããŸãããæéã¯ããé«ããšæãã人ãããŸããç¡æã®é£²ææ°Žãã¹ããã¯ãªã©ã®èŠçŽ ã¯ã4ã€æããã«ãšããŠã¯æå°éã§ãããšããæèŠããããŸããããå
šäœçãªçµéšã¯è¯å®çãªãã®ã§ããã
ã5ã€æã«å€ããããçŽ æŽããã4ã€æããã«ããšãã£ãè¯å®çãªãã¬ãŒãºã¯ãå€ãã®å®¿æ³å®¢ããã¹ãã¿ãªãã£ãšæœèšãé«ãè©äŸ¡ããŠããããšãåæ ããŠããŸããäžéšã®å®¿æ³å®¢ã¯ã以åã®èšªåã®éã®é«ãåºæºãæºãããŠããªãã£ããšææããæž
æœããå
šäœçãªäœéšãæ¹åããããšã§ãããã«è¯ããªããšè¿°ã¹ãŠããŸãã
ãŸãšãããšããã«ãã³ã»ãã³ãã³ã»ã¯ãã€ãã³ã¯ã匷åã§äžè²«ãããµãŒãã¹ãšé
åçãªã¢ãã³ãªæœèšãåãããè©å€ã®è¯ãããã«ã§ããã宿æ³å®¢ããé«ãè©äŸ¡ãåŸãŠããŸããããã€ãã®æ¹åã«ãããã²ã¹ããšã¯ã¹ããªãšã³ã¹ãããã«åäžãããããšãã§ããŸãããããã«ã¯ãããã4ã€æããã«ã®æåŸ
ã«å¿ããŠããŸãã